IND submission is a major milestone in the life of your drug. We can provide all supporting analytical data to help ensure a smooth application process.
We have the expertise, flexibility, and resources to provide a full range of pharmaceutical API custom development services at every stage of the lifecycle.
We can provide lab-, kilo- and pilot-scale manufacturing for preclinical studies and all phases of clinical trials, supplying milligram to kilogram quantities.
Cambrex brings more than 40 years of generic API manufacturing experience to its pharmaceutical partners. From our sites in Italy, Sweden, and the USA, we are a leading global supplier of generic APIs.
Cambrex offers cutting-edge capabilities in peptide development and manufacturing, combining innovative technologies, diverse applications and specialized expertise to meet the growing demand for peptide-based therapeutics.
Drug substance tech transfer sounds so simple on the surface, but it’s a complex activity carrying a number of technical, regulatory, and quality risks. Cambrex specializes in seamless technology transfers and quick onboarding to keep your program on track.
At Cambrex, we provide a range of technologies equipped to solve your API manufacturing challenges, and we are flexible enough to handle the most complex molecules.
At Snapdragon Chemistry, now part of Cambrex, our chemists specialize in creating custom solutions and technologies to take on your toughest process development and production challenges. This includes expertise in designing and building reactors that enable seamless technology transfer as a process scales up for commercial manufacturing.
You can rely on our extensive portfolio of analytical development solutions and testing services to rapidly advance your molecule for the greatest chance of success.
We’re solid state chemistry experts who can deliver timely, phase-appropriate solutions to optimize the physical stability of your API, develop a more bioavailable formulation or overcome other challenges.
Cambrex’s experienced analysts are well-equipped to ensure microbial testing is of the highest quality for our customers and delivered with a quick and reliable turnaround.
Cambrex and Q1 Scientific’s stability storage and sample management capabilities provide a variety of pharmaceutical storage conditions, with walk-in and reach-in chambers that meet all ICH Q1A requirements.
Cambrex offers extensive development services tailored to meet your drug product needs in early development. From pre-formulation to Phase II, we ensure your products are developed with speed, flexibility, and quality in mind.
Whether you need rapid development, flexible manufacturing solutions, or high-quality production, Cambrex is your trusted partner for advancing your drug product from concept to the clinic.
Cambrex is here to support you in early-phase development. Our development experts apply their ingenuity and skill to address your unique challenges.
Our teams of creative problem-solvers work closely with you to accelerate drug development timelines, optimize processes, and meet regulatory requirements.
We understand that the commercial phase of drug development can be challenging, especially when it comes to manufacturing at scale and meeting changing market demands.
Cambrex is a leading global supplier of more than 70 generic APIs, as well as intermediates and derivatives.
At Cambrex, our firm commitment to health, safety, and environmental sustainability underpins everything we do. We prioritize the well-being of our employees, customers, communities, and all those impacted by our activities and products. We adhere to the highest safety standards and operate preventively to avoid accidents and injuries.
As an integral part of every community in which we operate, we’ve established well-developed risk assessment methods that focus on safely handling and manufacturing our products. These include:
Our vision is to achieve zero workplace accidents, and we continually focus on improving our safety metrics to make that vision a reality.
At Cambrex, we promote strict environmental compliance and environmentally friendly initiatives at every facility. Each site has programs for reducing emissions and advancing sustainability, and we’re fully committed to continuous improvement in our environmental performance. Our efforts to find the most eco-friendly synthetic routes and processes include sustainable chemistry, advanced wastewater treatment methods and facilities, safe waste handling and management, periodically audited waste disposal facilities, and a commitment to emission reduction. We’re also REACH-compliant.
If you have any questions regarding our approach to environmental sustainability, health or safety, please contact us.
Across all Cambrex sites, the success of our health, safety, and environmental sustainability initiatives are characterized by our employees’ understanding, competence, and participation. Learn more about our environmental, social and governance (ESG) metrics used to track progress by watching our video.
As part of our commitment to transparency, Cambrex reports our decarbonization efforts annually to the Carbon Disclosure Project (CDP), a leading platform for reporting on climate impact that scores the maturity of ESG programs. The Cambrex CDP Climate score for 2024 was D, following a 2023 Climate score of C-. We believe the decline in score was a result of new essentials category requirements being applied to the C scoring category, which have been addressed in our 2025 submittal. Our expectation is that we will again be scored in the C category in 2025, which is the average Biotech Industry score. Cambrex is proud to share that for 2024, we have a number of subcategory scores in the B and A- categories.
Cambrex was scored for the first time in the water category and received a C scoring in 2024.
In both climate and water areas, we are engaged in carbon and water reduction programs at our manufacturing facilities. In 2025, we also had Science Based Targets validated by the Science Based Targets Initiative to achieve carbon reduction targets by 2030. More information on our Global commitments is contained in our Corporate Social Responsibility Policy.
Cambrex is also actively engaged in Sustainability with its customers and suppliers through implementation of a Supplier Code of Conduct. This is aligned with the Pharmaceutical Supply Chain Initiative (PSCI). More information on our programs can be found in the Cambrex Supplier Code of Conduct.
To learn more about our social responsibility and sustainability efforts, download our corporate policy.